Table 2

Dimensions of right upper lobe apical segmental bronchus (RB1) in patient groups and control subjects

Group A (n=20)Group B (n=16)Group C (n=25)Group D (n=38)Controls (n=16)p Value
Wall area (%)70.9 (1.6)70.4 (1.6)69.9 (1.4)70.3 (1.1)63.7 (1.0)0.009
Wall area/BSA (mm2/m2)12.5 (0.9)11.1 (1.3)13.1 (0.8)12.1 (0.6)13.9 (1.1)0.35
Lumen area/BSA (mm2/m2)5.4 (0.6)4.7 (0.6)5.7 (0.5)5.4 (0.4)7.9 (0.5)0.008
Total area/BSA (mm2/m2)17.9 (1.4)15.9 (1.8)18.8 (1.2)17.5 (1.0)21.8 (1.5)0.10
  • Data expressed as mean (SEM).

  • Intergroup comparisons: one-way ANOVA with Tukey test to compare all pairs of columns.

  • Group A, patients with severe asthma with a concordant asthma control score and eosinophilic inflammation with a significantly greater bronchodilator response; group B, patients with severe asthma who were predominantly women with high body mass index and evidence of a high asthma control score but very little eosinophilic airway inflammation; group C, patients with severe asthma with a predominantly high asthma control score and very little eosinophilic airway inflammation; group D, patients with severe asthma with predominantly eosinophilic airway inflammation and significantly low asthma control score.

  • BSA, body surface area.